Risk of myocardial infarction in trials with Dipeptidyl Peptidase-4 inhibitors: Is duration of study a real issue?

被引：4
作者：
Dicembrini, Ilaria [1 ]
Mannucci, Edoardo [1 ]
机构：
[1] Careggi Teaching Hosp, Diabetol, Florence, Italy
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2015年 / 184卷
关键词：
Type; 2; diabetes; Myocardial infarction; Dipeptidyl Peptidase 4 inhibitors; METAANALYSIS;
D O I：
10.1016/j.ijcard.2015.02.034
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：543 / 544
页数：2
相关论文
共 50 条
  • [31] Association between therapy with dipeptidyl peptidase-4 (DPP-4) inhibitors and risk of ileus: a cohort study
    Bennett D.
    Davé S.
    Sakaguchi M.
    Chang C.-H.
    Dolin P.
    Diabetology International, 2016, 7 (4) : 375 - 383
  • [32] Bullous pemphigoid and dipeptidyl peptidase-4 inhibitors: a meta-analysis of randomized controlled trials
    Silverii, Giovanni Antonio
    Dicembrini, Ilaria
    Nreu, Besmir
    Montereggi, Chiara
    Mannucci, Edoardo
    Monami, Matteo
    ENDOCRINE, 2020, 69 (03) : 504 - 507
  • [33] Risk of cancer in patients treated with dipeptidyl peptidase-4 inhibitors: an extensive meta-analysis of randomized controlled trials
    Dicembrini, Ilaria
    Nreu, Besmir
    Montereggi, Chiara
    Mannucci, Edoardo
    Monami, Matteo
    ACTA DIABETOLOGICA, 2020, 57 (06) : 689 - 696
  • [34] Risk of cancer in patients treated with dipeptidyl peptidase-4 inhibitors: an extensive meta-analysis of randomized controlled trials
    Ilaria Dicembrini
    Besmir Nreu
    Chiara Montereggi
    Edoardo Mannucci
    Matteo Monami
    Acta Diabetologica, 2020, 57 : 689 - 696
  • [35] Bullous pemphigoid and dipeptidyl peptidase-4 inhibitors: a meta-analysis of randomized controlled trials
    Giovanni Antonio Silverii
    Ilaria Dicembrini
    Besmir Nreu
    Chiara Montereggi
    Edoardo Mannucci
    Matteo Monami
    Endocrine, 2020, 69 : 504 - 507
  • [36] Dipeptidyl peptidase-4 inhibitors and the risk of community-acquired pneumonia in patients with type 2 diabetes
    Faillie, J. -L.
    Filion, K. B.
    Patenaude, V.
    Ernst, P.
    Azoulay, L.
    DIABETES OBESITY & METABOLISM, 2015, 17 (04) : 379 - 385
  • [37] Dipeptidyl Peptidase-4 Inhibitors and Heart Failure: Friends or Foes?
    Monami M.
    Mannucci E.
    Current Cardiovascular Risk Reports, 2015, 9 (8)
  • [38] Dipeptidyl peptidase-4 inhibitors and heart failure: A meta-analysis of randomized clinical trials
    Monami, M.
    Dicembrini, I.
    Mannucci, E.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2014, 24 (07) : 689 - 697
  • [39] Dipeptidyl peptidase-4 inhibitors may lower body temperature: A case-control study
    Okada, Shuichi
    Okada, Kazuya
    Okada, Junichi
    Kikkawa, Koji
    Yamada, Eijiro
    Saito, Tsugumichi
    Andou, Tetsuro
    Ohshima, Kihachi
    Niijima, Yawara
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2024, 18 (10)
  • [40] Dipeptidyl peptidase-4 inhibitors and risk of arthralgia: A systematic review and meta-analysis
    Men, P.
    He, N.
    Song, C.
    Zhai, S.
    DIABETES & METABOLISM, 2017, 43 (06) : 493 - 500
12345